Moderna (MRNA) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
4 figures withheld by our checks. Each blank figure names its reason.
431.0mn → 389.0mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
−81.7% YoY in FY25 · 9.9% of revenue.
$0.0B returned vs $−2.1B of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-145¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Net margin -145.2% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,525.0 | 1,944.0 | 3,236.0 | 6,848.0 | 19,263.0 | 18,471.0 | ▼39.9% | −43.0% |
Cost of revenue | 1,818.0 | 868.0 | 1,464.0 | 4,693.0 | 5,416.0 | 2,617.0 | ▼40.7% | −24.1% |
Gross profit | 707.0 | 1,076.0 | 1,772.0 | 2,155.0 | 13,847.0 | —A | ▼39.3% | −57.3% |
Research & development | 2,658.0 | 3,132.0 | 4,543.0 | 4,845.0 | 3,295.0 | 1,991.0 | ▼31.1% | +12.0% |
Selling, general & admin | 979.0 | 1,018.0 | 1,174.0 | 1,549.0 | 1,132.0 | 567.0 | ▼13.3% | +15.8% |
Total operating expenses | 3,637.0 | 4,150.0 | 5,717.0 | 6,394.0 | 4,427.0 | 2,558.0 | ▼27.4% | +12.9% |
Operating incomefeeds ROC rank | −2,930.0 | −3,074.0 | −3,945.0 | −4,239.0 | 9,420.0 | 13,296.0 | ▲22.1% | — |
Other income, net | 201.0 | 306.0 | 338.0 | 297.0 | 155.0 | −11.0 | — | — |
Pretax income | −2,729.0 | −2,768.0 | −3,607.0 | −3,942.0 | 9,575.0 | 13,285.0 | ▲23.3% | — |
Income tax | 60.0 | 54.0 | −46.0 | 772.0 | 1,213.0 | 1,083.0 | — | −52.7% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −2,789.0 | −2,822.0 | −3,561.0 | −4,714.0 | 8,362.0 | 12,202.0 | ▲20.8% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −7.09 | −7.26 | −9.28 | −12.33 | 20.12 | 28.29 | ▲21.8% | — |
Diluted shares (mn) | 430.00 | 389.00 | 384.00 | 382.00 | 416.00 | 431.00 | ▲1.3% | −2.5% |
| Margins | ||||||||
Gross margin11th pct in Healthcare | 28.0% | 55.3% | 54.8% | 31.5% | 71.9% | —A | ▲0.6pp | −16.5pp |
Operating margin | −116.0% | −158.1% | −121.9% | −61.9% | 48.9% | 72.0% | ▼36.2pp | −230.1pp |
Net margin9th pct in Healthcare | −110.5% | −145.2% | −110.0% | −68.8% | 43.4% | 66.1% | ▼35.1pp | −211.2pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Moderna's revenue last fiscal year?
Moderna reported revenue of $1,944.0M in fiscal 2025, down 39.9% from fiscal 2024.
What was Moderna's net income?
Moderna reported net income of −$2,822.0M in fiscal 2025, a net margin of −145.2%.

